High level of fluorescent oxidation products and worsening of asthma control over time

High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and ch...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 20; no. 1; pp. 203 - 4
Main Authors Akiki, Zeina, Andrianjafimasy, Miora, Zerimech, Farid, Le Moual, Nicole, Siroux, Valérie, Dumas, Orianne, Matran, Régis, Nadif, Rachel
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 06.09.2019
BioMed Central
BMC
Subjects
Adult
Adult asthma
Asthma
Asthma - diagnosis
Asthma - epidemiology
Asthma - metabolism
Asthma control
Biomarkers
Cohort Studies
Development and progression
Disease Progression
Epidemiology
Evolution
Female
Fluorescence
Fluorescent oxidation products
Health aspects
Humans
Letter to the Editor
Life Sciences
Longitude
Longitudinal studies
Longitudinal study
Male
Middle Aged
Oxidation
Oxidation-Reduction
Oxidative stress
Oxidative Stress - physiology
Polls & surveys
Santé publique et épidémiologie
Sex ratio
Smoking
Young Adult
France
Adult asthma
Oxidative stress
Asthma control
Fluorescent oxidation products
Epidemiology
Longitudinal study
Online AccessGet full text

Cover

Abstract High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 (± 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
AbstractList High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 (± 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 ([+ or -] 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 ([+ or -] 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management. Keywords: Fluorescent oxidation products, Oxidative stress, Adult asthma, Asthma control, Longitudinal study, Epidemiology
Abstract High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 (± 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32–3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
ArticleNumber 203
Audience Academic
Author Le Moual, Nicole
Zerimech, Farid
Akiki, Zeina
Andrianjafimasy, Miora
Siroux, Valérie
Matran, Régis
Nadif, Rachel
Dumas, Orianne
Author_xml – sequence: 1
  givenname: Zeina
  surname: Akiki
  fullname: Akiki, Zeina
  organization: INSPECT-LB : Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie, Faculty of Public Health, Lebanese University, Beirut, Lebanon
– sequence: 2
  givenname: Miora
  orcidid: 0000-0002-5791-0772
  surname: Andrianjafimasy
  fullname: Andrianjafimasy, Miora
  email: miora.andrianjafimasy@inserm.fr, miora.andrianjafimasy@inserm.fr
  organization: Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, Versailles, France. miora.andrianjafimasy@inserm.fr
– sequence: 3
  givenname: Farid
  surname: Zerimech
  fullname: Zerimech, Farid
  organization: EA4483, IMPECS, Institut Pasteur de Lille, Université de Lille, F-59000, Lille, France
– sequence: 4
  givenname: Nicole
  surname: Le Moual
  fullname: Le Moual, Nicole
  organization: Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, Versailles, France
– sequence: 5
  givenname: Valérie
  surname: Siroux
  fullname: Siroux, Valérie
  organization: Institute for Advanced Biosciences, Centre de recherche UGA-Inserm U1209-CNRS UMR 5309, équipe d'épidémiologie environnementale, Site Santé, Allée des Alpes, F-38700, La Tronche, France
– sequence: 6
  givenname: Orianne
  surname: Dumas
  fullname: Dumas, Orianne
  organization: Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, Versailles, France
– sequence: 7
  givenname: Régis
  surname: Matran
  fullname: Matran, Régis
  organization: Univ Lille Nord de France, F-59000, Lille, France
– sequence: 8
  givenname: Rachel
  surname: Nadif
  fullname: Nadif, Rachel
  organization: Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, Versailles, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31492144$$D View this record in MEDLINE/PubMed
https://inserm.hal.science/inserm-02939813$$DView record in HAL
BookMark eNptUstuEzEUHaEi-oAPYINGYssU37HHjw1SVAGpFIlNhdhZjh8TRzN2sCcp_D0eUkqDkBfXuj7n3IfPZXUWYrBV9RrQNQCn7zO0AkODQDQADDfoWXUBhHaNEPjb2ZP7eXWZ8xYhYJx1L6pzDES0QMhF9XXp-0092IMd6uhqN-xjslnbMNXxhzdq8jHUuxTNXk-5VsHU9zFlG3zoZ7zK02ZUtY5hSrEoHGyqJz_al9Vzp4ZsXz3Eq-ru08e7m2Wz-vL59maxanQn2NRgqphypgTRYs6h40i1a2cpR0xpJQwlgpXRjHKagVVGEM0MdBY7yzuBr6rbo6yJait3yY8q_ZRRefk7EVMvVZq8HqxkBDkqShkKnBBYr63hGGHKuFkrQlTR-nDU2u3XozXzCpIaTkRPX4LfyD4eJGUYOoqKwLujwOYf2nKxkj5km0aJyocJDvgABf72oV6K3_c2T3Ib9ymUbcm2FS2jpPT2F9WrMoQPLpbaevRZywVFqG1xi1hBXf8HVY6xoy-fY50v-RMCHAk6xZyTdY8NA5Kzt-TRW7J4S87ekvN8b54u6JHxx0z4Fzjqyqw
CitedBy_id crossref_primary_10_1016_j_jocd_2021_09_003
crossref_primary_10_1016_j_isci_2023_105991
crossref_primary_10_3390_antiox11050802
crossref_primary_10_1136_bmjresp_2020_000632
Cites_doi 10.1161/JAHA.113.000195
10.1159/000342330
10.1016/S0140-6736(15)00156-7
10.1111/j.1749-6632.2010.05600.x
10.1038/nm.2678
10.1093/aje/kwm119
10.1089/ars.2012.5149
10.1016/j.jaci.2015.10.029
10.1016/S0140-6736(17)30879-6
10.1093/aje/kwm120
10.1183/13993003.01193-2017
10.1111/j.1365-2222.1995.tb00413.x
10.1016/j.jaci.2014.12.1871
10.1111/all.12865
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: The Author(s). 2019
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PIMPY
PQEST
PQQKQ
PQUKI
1XC
VOOES
5PM
DOA
DOI 10.1186/s12931-019-1173-0
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE



Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
1465-9921
EndPage 4
ExternalDocumentID oai_doaj_org_article_740f69923618441bbed8303678dba44a
oai_HAL_inserm_02939813v1
A600223207
10_1186_s12931_019_1173_0
31492144
Genre Letter
GeographicLocations France
GeographicLocations_xml – name: France
GrantInformation_xml – fundername: French Agency for Food, Environmental and Occupational Health & Safety; Merck Sharp & Dohme (MSD); the hospital program of clinical research (PHRC)-Paris; the National Research Agency - Health Environment, Health-Work Program; the Region Nord Pas-de-Calais
  grantid: ANSES/AFSSET, EST- 09-15, PNR-EST 2017; ANR 05-SEST-020-02/05-9-97, ANR CES-2009
– fundername: ;
  grantid: ANSES/AFSSET, EST- 09–15, PNR-EST 2017; ANR 05-SEST-020-02/05-9-97, ANR CES-2009
GroupedDBID ---
-A0
0R~
29P
2WC
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PQEST
PQUKI
1XC
2VQ
AHSBF
H13
IPNFZ
VOOES
5PM
AFPKN
ID FETCH-LOGICAL-c597t-36a7afd36a923881580a2bfe6807aca9d6497117dafc71ead94c7d15e3fe8593
IEDL.DBID RPM
ISSN 1465-993X
1465-9921
IngestDate Tue Oct 22 14:57:46 EDT 2024
Tue Sep 17 21:21:55 EDT 2024
Tue Oct 15 15:27:28 EDT 2024
Sat Nov 09 08:44:40 EST 2024
Tue Nov 19 21:02:51 EST 2024
Tue Nov 12 22:40:47 EST 2024
Fri Dec 06 03:22:02 EST 2024
Wed Oct 16 00:46:14 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Adult asthma
Oxidative stress
Asthma control
Fluorescent oxidation products
Epidemiology
Longitudinal study
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-36a7afd36a923881580a2bfe6807aca9d6497117dafc71ead94c7d15e3fe8593
Notes PMCID: PMC6731560
ORCID 0000-0002-5791-0772
0000-0003-4442-0026
0000-0003-4938-9339
0000-0002-2723-5569
0000-0001-8423-2826
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731560/
PMID 31492144
PQID 2292764678
PQPubID 42864
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_740f69923618441bbed8303678dba44a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6731560
hal_primary_oai_HAL_inserm_02939813v1
proquest_journals_2292764678
gale_infotracmisc_A600223207
gale_infotracacademiconefile_A600223207
crossref_primary_10_1186_s12931_019_1173_0
pubmed_primary_31492144
PublicationCentury 2000
PublicationDate 2019-09-06
PublicationDateYYYYMMDD 2019-09-06
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-06
  day: 06
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Respiratory research
PublicationTitleAlternate Respir Res
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References R Beasley (1173_CR1) 2015; 386
SE Wenzel (1173_CR4) 2012; 18
F Kauffmann (1173_CR12) 1995; 25
CM Rebholz (1173_CR9) 2012; 36
V Siroux (1173_CR14) 2016; 137
KF Chung (1173_CR5) 2010; 1203
T Wu (1173_CR15) 2007; 166
M Mittal (1173_CR6) 2014; 20
T Wu (1173_CR8) 2007; 166
MK Jensen (1173_CR7) 2013; 2
FM Aldakheel (1173_CR17) 2016; 71
ML Fajt (1173_CR3) 2015; 135
M Andrianjafimasy (1173_CR10) 2017; 50
F Kauffmann (1173_CR11) 1999; 29
ID Pavord (1173_CR2) 2018; 391
1173_CR16
1173_CR13
References_xml – volume: 2
  start-page: 1
  year: 2013
  ident: 1173_CR7
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.113.000195
  contributor:
    fullname: MK Jensen
– volume: 36
  start-page: 297
  year: 2012
  ident: 1173_CR9
  publication-title: Am J Nephrol
  doi: 10.1159/000342330
  contributor:
    fullname: CM Rebholz
– ident: 1173_CR16
– volume: 386
  start-page: 1075
  year: 2015
  ident: 1173_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)00156-7
  contributor:
    fullname: R Beasley
– volume: 1203
  start-page: 85
  year: 2010
  ident: 1173_CR5
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2010.05600.x
  contributor:
    fullname: KF Chung
– volume: 18
  start-page: 716
  year: 2012
  ident: 1173_CR4
  publication-title: Nat Med
  doi: 10.1038/nm.2678
  contributor:
    fullname: SE Wenzel
– volume: 166
  start-page: 552
  year: 2007
  ident: 1173_CR15
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm119
  contributor:
    fullname: T Wu
– volume: 20
  start-page: 1126
  year: 2014
  ident: 1173_CR6
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2012.5149
  contributor:
    fullname: M Mittal
– volume: 137
  start-page: 1709
  year: 2016
  ident: 1173_CR14
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.10.029
  contributor:
    fullname: V Siroux
– volume: 391
  start-page: 350
  issue: 10118
  year: 2018
  ident: 1173_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)30879-6
  contributor:
    fullname: ID Pavord
– volume: 166
  start-page: 544
  issue: 5
  year: 2007
  ident: 1173_CR8
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm120
  contributor:
    fullname: T Wu
– volume: 50
  year: 2017
  ident: 1173_CR10
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01193-2017
  contributor:
    fullname: M Andrianjafimasy
– volume: 25
  start-page: 19
  issue: Suppl 2
  year: 1995
  ident: 1173_CR12
  publication-title: Clin Exp Allergy J Br Soc Allergy Clin Immunol
  doi: 10.1111/j.1365-2222.1995.tb00413.x
  contributor:
    fullname: F Kauffmann
– volume: 135
  start-page: 299
  year: 2015
  ident: 1173_CR3
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2014.12.1871
  contributor:
    fullname: ML Fajt
– volume: 71
  start-page: 741
  issue: 6
  year: 2016
  ident: 1173_CR17
  publication-title: Allergy
  doi: 10.1111/all.12865
  contributor:
    fullname: FM Aldakheel
– volume: 29
  start-page: 17
  issue: Suppl 4
  year: 1999
  ident: 1173_CR11
  publication-title: Clin Exp Allergy
  contributor:
    fullname: F Kauffmann
– ident: 1173_CR13
SSID ssj0017875
Score 2.330557
Snippet High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its...
Abstract High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but...
SourceID doaj
pubmedcentral
hal
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 203
SubjectTerms Adult
Adult asthma
Asthma
Asthma - diagnosis
Asthma - epidemiology
Asthma - metabolism
Asthma control
Biomarkers
Cohort Studies
Development and progression
Disease Progression
Epidemiology
Evolution
Female
Fluorescence
Fluorescent oxidation products
Health aspects
Humans
Letter to the Editor
Life Sciences
Longitude
Longitudinal studies
Longitudinal study
Male
Middle Aged
Oxidation
Oxidation-Reduction
Oxidative stress
Oxidative Stress - physiology
Polls & surveys
Santé publique et épidémiologie
Sex ratio
Smoking
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QFQcsjUCofipCQojovP44Lolohyqmg3iw_tZXapNpsCz-fmdi7auDAhVOkeORY8_DMZMafCTmOEIRLq1zJlGnLVnhbWmFF6YWwwfDKN1P1_OwbX35vv1x0F_eu-sKesAQPnBh3IloWuVKIESLBdVsbvMRtV0hvTdum0IjV22Qq1w9ADbtcw6wkPxnRq2HarMqqEk3JZl5oAuvfbckPV9gR-Xe4-WfX5D03dPqUPMnxI12kdT8jD0K_Tx6d5Qr5AfmBjRv0CluB6BBpvLod1gmxiQ6_LtMFSvQmwbyO1PSe_hzWY8C_I0hvxs3q2tDcwE6xv5Pi9fPPyfnp5_NPyzLfnVA6SBE2ZcONMNHDA1gnZdVJZmobA5dMGGeU560SwAtvohMVqJNqnfBVF5oYEALtBdnrhz68ItRByiXqOhoeeWtDVIYZBWLoYohOOV-QD1tW6puEkKGnzEJynfiuge8IKt5oVpCPyOwdIYJbTy9A5DqLXP9L5AV5j6LSaIIgCWfySQJYL4JZ6QXWGiFSZKIghzNKMB03G34Hwp4tZrn4CtRg_deawdqVrJq7CqbZqoPOJj7qula14OBnZEFeJs3YzdRA3olYdAURM52ZfWo-0l-uJnBvLho83P76fzDqDXlco85j_Ysfkr3N-ja8hRhqY48mc_kNnjgYPA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_2CuKL-O1qlTwoghC6n_l4kqu0HGKLSJV7C_nsFdrb8_aq_vnO7OZOV8GnhU1IwmQmM5OZ_IaQVxGMcGmVY7kyNauFt8wKK5gXwgbDC1_10fPTMz77Un-YN_N04daltMrtmdgf1L51eEd-WJaqFBzEWr5bfWNYNQqjq6mExh7ZL4tKygnZPzo--_R5F0cAdmyG90UNA008T3HNQvLDDjUdutKKFYWoWD7STD2A_-6Y3ltgluS_JujfmZR_qKaTe-RusinpdGCC--RWWD4gt09T1Pwh-YrJHPQK04NoG2m8umnXA4oTbX9eDkWV6GqAfu2oWXr6o113AW9MsL_pNotrQ1NSO8WcT4ol6R-R85Pj8_czluopMAduw4ZV3AgTPXzAqpOyaGRuShsDl7kwzijPayWAFt5EJwpgMVU74YsmVDEgLNpjMlm2y_CUUAdumCjLaHjktQ1Rmdwoa0MTQ3TK-Yy83ZJSrwbUDN17G5Lrge4a6I5A45XOM3KExN51RMDr_ke7vtBJfrSo88iVQqgYCRYczOUlal8hvTV1bTLyBrdKo1jCTjiTXhfAehHgSk8x_gjWYy4ycjDqCeLkRs2vYbNHi5lNP0JvOBGudQ5rV7KovhcwzJYddBL7Tv9m0ow8GThjN1IFviji02VEjHhmNNW4ZXm56AG_uajwwfuz_0_5nNwpkZsx2sUPyGSzvgkvwGLa2JdJLH4BmNMUSQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKkRAXxJtAQT6AkJAMeTh-HBBaENUKsZxatDfLju1upW1Ski2Uf89Mkl0I9MIpUmI51vibzExm_A0hzyM44crpiqXacsald8xJJ5mX0gUrMl_02fPFFzE_5p-W5XKPbNtbjQLsrgztsJ_Ucbt-ffnt5ztQ-Le9wivxpkObhUGxZlkmCwYR_PUcDCNWeC3476QCYLMcDhuVDMzyckxyXjnFxEz1bP67b_a1FZZM_uuP_l1W-YedOrxNbo0OJp0NiLhD9kJ9l9xYjCn0e-QrVnbQNdYK0SbSuL5o2oHSiTaXp0OHJXo-8MB21Nae_mjaLuDvExxvu83qzNKxwp1iASjF_vT3ydHhx6MPczY2V2AVxBAbVggrbfRwARdPqaxUqc1dDEKl0lZWe8G1BFl4GyuZAd40r6TPylDEgBxpD8h-3dThEaEVxGQyz6MVUXAXorap1c6FMoZY6con5NVWlOZ8oNAwfeihhBnkbkDuyDpemDQh71HYu4HIft3faNoTMyqTkTyNQmvkjVHgzsG7vEJTLJV3lnObkJe4VQZRAztR2fGoAawX2a7MDJOR4EqmMiEHk5GgW9Xk8QvY7Mli5rPPMBo-D2cmhbVrlRXfM5hmCwezhbDJc51LAYZIJeThgIzdTAUEpkhWlxA5wczkVdMn9emqZ_8WssDT74__R6pPyM0csY2JMHFA9jftRXgKztTGPetV5BcEjxlU
  priority: 102
  providerName: Scholars Portal
Title High level of fluorescent oxidation products and worsening of asthma control over time
URI https://www.ncbi.nlm.nih.gov/pubmed/31492144
https://www.proquest.com/docview/2292764678
https://inserm.hal.science/inserm-02939813
https://pubmed.ncbi.nlm.nih.gov/PMC6731560
https://doaj.org/article/740f69923618441bbed8303678dba44a
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6SFEovpe-qTc0eWgoFxXqs9nF0QoIpdQglLb4t-9DGBlsyttP253dGD1O1t15kkNbSsjOjmdF8-w0h7wME4dIqFyfKsJgJb2MrrIi9ELY0PPV5Uz2fXfPpN_Z5XsyPSNHvhWlA-84uz6rV-qxaLhps5Wbtxj1ObHwzu-Aixw3A42NyDO63T9G70gFoYNFuKSpipbK0K2Wmko936Nwwe1Zxmoo8xjZwOaQISBs28EsNff_hJX28QIzkvwHo3zjKPxzT1RPyuIso6aSd-VNyVFbPyMNZVzN_Tr4jlIOuEBxE60DD6r7ethxOtP61bFsq0U1L_LqjpvL0Z73dlfi9BMeb3X6xNrSDtFNEfFJsSP-C3F5d3l5M466bQuwgadjHOTfCBA8_ENNJmRYyMZkNJZeJMM4oz5kSsCzeBCdSUDDFnPBpUeahRFK0l-SkqqvyNaEOlktkWTA8cGbLoExilLVlEcrglPMR-dQvpd60nBm6yTUk160INIgAacZznUTkHBf7MBDprpsT9fZOd0LXgiWBgzBzbE_DUniWl-h7hfTWMGYi8hFFpdEoQRLOdHsLYL5Ib6UnWH2E2DERETkdjARjcoPLH0DYg8lMJ19gNLwP1jqBuSuZ5j9SuE2vDroz-p3OMpUJDp5HRuRVqxmHO_VqFhEx0JnBo4ZXQPsbuu9O29_89z_fkkcZ6jyWwfgpOdlv78t3EErt7QgMaC5G5MH55fXN11HzQQKOMyZHjVH9BrMGH98
link.rule.ids 230,314,727,780,784,864,885,2102,12056,21388,24318,27924,27925,31719,33744,43310,43805,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEA9eD9QX8dvVU_OgCMJy-5mPJ-nJHVXbIlKlbyEfG3twt1u7PfXPd2Y3ra6CTwubkITJTGYmM_kNIS88GOHCSBsnUhdxwZ2JDTc8dpybSrPU5V30fDZnk8_F-2W5DBdubUir3J2J3UHtGot35MdZJjPOQKzFm_W3GKtGYXQ1lNA4IIeInF6OyOHJ6fzjp30cAdix7N8XlTFo4mWIa6aCHbeo6dCVlnGa8jxOBpqpA_DfH9MHK8yS_NcE_TuT8g_VdHab3Ao2JR33THCHXKvqu-T6LETN75EvmMxBLzA9iDae-ourZtOjONHm53lfVImue-jXlura0R_Npq3wxgT763a7utQ0JLVTzPmkWJL-PlmcnS7eTuJQTyG24DZs45xprr2DD1h1QqSlSHRmfMVEwrXV0rFCcqCF097yFFhMFpa7tKxyXyEs2gMyqpu6ekSoBTeMZ5nXzLPCVF7qREtjqtJX3krrIvJ6R0q17lEzVOdtCKZ6uiugOwKN5yqJyAkSe98RAa-7H83mqwryo3iReCYlQsUIsOBgLidQ-3LhjC4KHZFXuFUKxRJ2wurwugDWiwBXaozxR7AeEx6Ro0FPECc7aH4Jmz1YzGQ8hd5wIlyqBNYuRZp_T2GYHTuoIPat-s2kEXnYc8Z-pBx8UcSniwgf8MxgqmFLfb7qAL8Zz_HB--P_T_mc3JgsZlM1fTf_8ITczJCzMfLFjshou7mqnoL1tDXPgoj8AqTMFzE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIlVcEG8MBfYAQkJy4_VjH8dQiAI0VQ8F9bbah7eJlNhRnAI_nxnbiWq4cbJkr-3VzjeeGc_sN4S8DeCES6tcnCiTx7nwNrbCitgLYUvDmc_a7PnsnE-_51-viqtbrb7aon1nFyfVcnVSLeZtbeV65Ua7OrHRxeyUiww3AI_WPowOyN0iA5DtAvU-gQA4LLqNRUWsVMr6hCaTfNSgicMYWsWMiSzGZnAZBApIHjawTi2J__5TfTDHSsl_3dC_qylvmafJA3K_9yvpuJv_Q3KnrB6Ro1mfOX9MfmBBB11iiRCtAw3Lm3rTMTnR-veia6xE1x39a0NN5emvetOU-NcEx5tmO18Z2he2U6z7pNiW_gm5nHy-PJ3GfU-F2EHosI0zboQJHg7g2UnJCpmY1IaSy0QYZ5TnuRKwLN4EJxjATOVOeFaUWSiRGu0pOazqqnxOqIPlEmkaDA88t2VQJjHK2rIIZXDK-Yh82C2lXnfMGbqNOCTXnQg0iADJxjOdROQjLvZ-IJJetyfqzbXuRa9FngQOwsywSU3O4F1eogUW0luT5yYi71FUGlUTJOFMv8MA5oskV3qMOUjwIBMRkePBSFApN7j8DoQ9mMx0fAaj4auw0gnMXUmW_WTwmB0cdK_6jU5TlQoO9kdG5FmHjP2TdjCLiBhgZvCq4RXQgZb0u8f8i_--8w05uvg00Wdfzr-9JPdShD_mxfgxOdxubspX4Ftt7etWi_4A3dsf9w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+level+of+fluorescent+oxidation+products+and+worsening+of+asthma+control+over+time&rft.jtitle=Respiratory+research&rft.au=Akiki%2C+Zeina&rft.au=Andrianjafimasy%2C+Miora&rft.au=Zerimech%2C+Farid&rft.au=Le+Moual%2C+Nicole&rft.date=2019-09-06&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-019-1173-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_019_1173_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon